• Profile
Close

Delayed initial radioiodine therapy related to incomplete response in low- to intermediate-risk differentiated thyroid cancer

Clinical Endocrinology Jan 20, 2019

Li H, et al. - In this retrospective review, researchers assessed the impact of the initiating time of radioiodine (RAI) therapy on response to initial therapy in 235 consecutive patients with low- to intermediate-risk differentiated thyroid cancer (DTC). In addition, univariate and multivariate analyses were carried out to identify factors related to incomplete response (IR). Both T status and N status, stimulated thyroglobulin, and time intervals were important risk factors for IR by univariate analysis. Multivariate analysis showed that the time interval was an independent risk factor for IR. According to findings, delayed initial RAI therapy (≥3 months after thyroidectomy) correlated with incomplete response in low- to intermediate-risk DTC patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay